CBIO
Crescent Biopharma
CBIO
CBIO
41 hedge funds and large institutions have $7.56M invested in Crescent Biopharma in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.19% more ownership
Funds ownership: 0.28% → 0.47% (+0.19%)
Holders
41
Holding in Top 10
–
Calls
$26K
Puts
–
Top Buyers
| 1 | +$1.34M | |
| 2 | +$1.27M | |
| 3 | +$747K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$352K |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$106K |
Top Sellers
| 1 | -$332K | |
| 2 | -$184K | |
| 3 | -$42.1K | |
| 4 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
-$16.9K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$14K |